TransMedics Group, Inc. - COM (TMDX)

Historical Portfolio Holders from Q2 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
33.5 M
Holdings value Q1 2024
$2.48 B
Value change Q1 2024
-$66.9 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
240
Number of buys Q1 2024
133
Number of sells Q1 2024
-111
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.001%
CUSIP
89377M109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 33.5 M $2.48 B -$66.9 M $73.94 242
2023 Q4 34.2 M $2.7 B -$3.71 M $78.93 240
2023 Q3 34.9 M $1.91 B +$74.7 M $54.75 217
2023 Q2 32.4 M $2.72 B +$225 M $83.98 236
2023 Q1 29.8 M $2.26 B +$69.3 M $75.73 220
2022 Q4 28.9 M $1.78 B +$25.5 M $61.72 194
2022 Q3 26.5 M $1.11 B +$218 M $41.74 170
2022 Q2 22.8 M $717 M +$64.9 M $31.45 127
2022 Q1 20.6 M $556 M +$24 M $26.94 102
2021 Q4 18.5 M $354 M +$28.8 M $19.16 111
2021 Q3 19.2 M $636 M +$13.2 M $33.09 117
2021 Q2 17.3 M $573 M +$771 K $33.18 117
2021 Q1 18.6 M $773 M -$21 M $41.49 106
2020 Q4 21.3 M $424 M -$4.48 M $19.90 67
2020 Q3 20.6 M $284 M +$4.47 M $13.78 69
2020 Q2 19.3 M $346 M +$89.5 M $17.92 66
2020 Q1 15 M $181 M -$2.35 M $12.08 49
2019 Q4 11.8 M $224 M +$60 M $19.01 56
2019 Q3 11.8 M $277 M +$5.6 M $23.75 45
2019 Q2 13.7 M $384 M +$384 M $28.99 56